Favorable response to antigonadal therapy for a benign metastasizing leiomyoma.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 22270431.
- Also identified by DOI 10.1097/AOG.0b013e318240090e and PMC identifier 3266540.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Benign metastasizing leiomyoma and lymphangioleiomyomatosis (LAM) both are characterized by abnormal proliferation of smooth muscle-like cells in the lung. A 32-year-old African woman with a diagnosis of LAM underwent myomectomy for uterine leiomyomas. An alternative diagnosis of benign metastasizing leiomyoma was made on repeat lung biopsy. Treatment with leuprolide acetate decreased pulmonary infiltrates and improved lung function and exercise tolerance. Accurately diagnosing benign metastasizing leiomyoma has important implications for clinical outcome. Because its clinical presentation may be misleading, immunohistochemical techniques may assist in differentiating benign metastasizing leiomyoma from LAM. This is important because, in benign metastasizing leiomyoma, reduced tumor burden and improved pulmonary function may be achieved by suppressing gonadal steroids.
Medical subject headings
- Leiomyoma
- Lung Neoplasms
- Lymphangioleiomyomatosis
- Uterine Neoplasms